US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist
  • 6.785
  • -0.095-1.38%
Trading Nov 21 10:36 ET
1.87BMarket Cap84.81P/E (TTM)

About MannKind Company

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Company Profile

SymbolMNKD
Company NameMannKind
Listing DateJul 28, 2004
Issue Price14.00
Founded1991
CEOMr. Michael E. Castagna, Pharm.D.
MarketNASDAQ
Employees414
Fiscal Year Ends12-31
Address1 Casper Street
CityDanbury
ProvinceConnecticut
CountryUnited States of America
Zip Code06810
Phone1-818-661-5000
Websitehttp://www.mannkindcorp.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael E. Castagna, Pharm.D.
  • Director and Chief Executive Officer
  • 7.07M
  • Lauren M. Sabella
  • Executive Vice President and Chief Operating Officer
  • 1.91M
  • Dr. Burkhard Blank,M.D.
  • Executive Vice President, Research and Development and Chief Medical Officer
  • --
  • Stuart A. Tross, PhD
  • Executive Vice President, Chief People and Workplace Officer
  • 2.22M
  • Christopher B. Prentiss
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Sanjay R. Singh
  • Executive Vice President, Technical Operations
  • --
  • Dr. David B. Thon, J.D.
  • Executive Vice President, General Counsel and Secretary
  • 2.34M
  • Dr. James S. Shannon, M.D.,M.R.C.P.
  • Chairman of the Board
  • 255.64K
  • Steven B. Binder
  • Director
  • 2.34M
  • Dr. Michael A. Friedman M.D.
  • Independent Director
  • 229.23K
  • Sabrina Kay
  • Independent Director
  • 221.73K
  • Anthony C. Hooper
  • Independent Director
  • 233.14K
  • Christine A. Mundkur
  • Independent Director
  • 226.73K
  • Jennifer Grancio
  • Independent Director
  • 221.73K
  • Ronald J. Consiglio
  • Independent Director
  • 241.73K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data